Q4 2018 Unum Therapeutics Inc Earnings Call Transcript

Mar 28, 2019 / 12:00PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Unum Therapeutics Fourth Quarter 2018 Results Conference Call. (Operator Instructions)

I would now like to hand the call over to Ms. Stephanie Ascher. You may begin.

Stephanie Baritz Ascher - Stern Investor Relations, Inc. - SVP

Good morning and welcome to the Unum Therapeutics quarterly investor conference call. Today, we'll be sharing updates on our company's progress and our financial results for the fourth quarter ended December 31, 2018, and full year of 2018. With me on our call today are Chuck Wilson, CEO; Michael Vasconcelles, Chief Medical Officer; Seth Ettenberg, Chief Scientific Officer; and John Green, Vice President, Finance. Following our prepared remarks, we'll open the line for questions.

Before we begin our prepared remarks, I need to remind you that estimates and other forward-looking statements included in this call represent the company's view as of today, March 28, 2019. Unum Therapeutics disclaims any obligation to update these statements to reflect future events or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot